{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:10:52Z","timestamp":1791461452846,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.imbio.2015.12.007","type":"journal-article","created":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T18:45:49Z","timestamp":1450205149000},"page":"516-527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein\u2013Barr virus infection"],"prefix":"10.1016","volume":"221","author":[{"given":"Paola","family":"Cavalcante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Galbardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Franzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Marcuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Barzago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bonanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Camera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimos","family":"Kapetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Andreetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Biasiucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresio","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Giardina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Antozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Baggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2015.12.007_bib0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imbio.2015.12.007_bib0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mus.22103","article-title":"The thymus in myasthenia gravis: site of innate autoimmunity?","volume":"44","author":"Cavalcante","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.imbio.2015.12.007_bib0015","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.autrev.2013.03.010","article-title":"Etiology of myasthenia gravis: innate immunity signature in pathological thymus","volume":"12","author":"Cavalcante","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imbio.2015.12.007_bib0020","first-page":"1218","volume":"vol. I","author":"M\u00fcller-Hermelink","year":"1996"},{"key":"10.1016\/j.imbio.2015.12.007_bib0025","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.autrev.2013.03.011","article-title":"Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis","volume":"12","author":"Berrih-Aknin","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imbio.2015.12.007_bib0030","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ana.410280303","article-title":"Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor specific T cells","volume":"28","author":"Sommer","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0035","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.4049\/jimmunol.145.7.2115","article-title":"Thymic B cells from myasthenia gravis patients are activated B cells phenotypic and functional analysis","volume":"145","author":"Leprince","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jneuroim.2008.06.027","article-title":"The myasthenia gravis thymus: a rare source of human autoantibody-secreting plasma cells for testing potential therapeutics","volume":"201\u2013202","author":"Hill","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0045","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.autrev.2007.11.006","article-title":"Toll-like receptors and autoimmunity","volume":"7","author":"Hurst","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imbio.2015.12.007_bib0050","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nri2527","article-title":"Antiviral immune responses: triggers of or triggered by autoimmunity?","volume":"9","author":"M\u00fcnz","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0002-9440(10)62960-4","article-title":"Increased Toll-like receptor 4 expression in thymus of myasthenia gravis patients","volume":"167","author":"Bernasconi","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jneuroim.2008.06.028","article-title":"Thymus and myasthenia gravis: what can we learn from DNA microarrays?","volume":"201","author":"Cizeron-Clairac","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0065","doi-asserted-by":"crossref","first-page":"281e93","DOI":"10.1002\/ana.23791","article-title":"Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis","volume":"73","author":"Cufi","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2013.12.013","article-title":"Innate immunity in myasthenia gravis thymus: pathogenic effects of Toll-like receptor 4 signaling on autoimmunity","volume":"52","author":"Cordiglieri","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imbio.2015.12.007_bib0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.it.2007.03.002","article-title":"Epstein\u2013Barr virus latent membrane protein 2A and autoimmunity","volume":"28","author":"Swanson-Mungerson","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0080","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/978-1-4419-8216-2_7","article-title":"Epigenetic dysregulation of Epstein\u2013Barr virus latency and development of autoimmune disease","volume":"711","author":"Niller","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0085","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.21902","article-title":"Epstein\u2013Barr virus persistence and reactivation in myasthenia gravis thymus","volume":"67","author":"Cavalcante","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0090","first-page":"213092","article-title":"Inflammation and epstein-barr virus infection are common features of myasthenia gravis thymus: possible roles in pathogenesis","volume":"2011","author":"Cavalcante","year":"2011","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.imbio.2015.12.007_bib0095","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.4049\/jimmunol.177.5.2793","article-title":"EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity","volume":"177","author":"Wang","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0100","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1749-6632.2009.05123.x","article-title":"Innate pathways to B-cell activation and tolerance","volume":"1183","author":"Crampton","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.imbio.2015.12.007_bib0105","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/eji.200535744","article-title":"Toll-like receptor stimulation as a third signal required for activation of human naive B cells","volume":"36","author":"Ruprecht","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0110","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0115","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri1957","article-title":"Toll-like receptors in systemic autoimmune disease","volume":"6","author":"Marshak-Rothstein","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0120","doi-asserted-by":"crossref","first-page":"9748","DOI":"10.1128\/JVI.01122-07","article-title":"Manipulation of the toll-like receptor 7 signaling pathway by Epstein\u2013Barr virus","volume":"81","author":"Martin","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0125","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.4049\/jimmunol.0903736","article-title":"TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells","volume":"185","author":"Fiola","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2042-4280-2-1","article-title":"Innate immune modulation in EBV infection","volume":"2","author":"Ning","year":"2011","journal-title":"Herpesviridae"},{"key":"10.1016\/j.imbio.2015.12.007_bib0135","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1128\/JVI.01400-09","article-title":"Toll-like receptor agonists synergistically increase proliferation and activation of B cells by epstein-barr virus","volume":"84","author":"Iskra","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0140","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1097\/PAS.0b013e318166f46a","article-title":"Expression of the interferon regulatory factor 8\/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker","volume":"32","author":"Martinez","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20051450","article-title":"Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8\/IFN consensus sequence-binding protein","volume":"203","author":"Lee","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2015.12.007_bib0150","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/eji.201242552","article-title":"EBV stimulates TLR- and autophagy-dependent pathways and impairs maturation in plasmacytoid dendritic cells: implications for viral immune escape","volume":"43","author":"Severa","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0155","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.tim.2014.12.003","article-title":"Mx GTPases: dynamin-like antiviral machines of innate immunity","volume":"23","author":"Haller","year":"2015","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0160","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/jcp.21128","article-title":"Central role of interferon regulatory factor-1 (IRF-1) in controlling retinoic acid inducible gene-I (RIG-I) expression","volume":"213","author":"Su","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0165","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/WCO.0b013e328364d6cd","article-title":"Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation","volume":"26","author":"Le Panse","year":"2013","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0170","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaut.2009.10.001","article-title":"Emerging roles of TLR7 and TLR9 in murine SLE","volume":"33","author":"Santiago-Raber","year":"2009","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imbio.2015.12.007_bib0175","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/art.21278","article-title":"The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7\/8 results in synergistic cytokine production by dendritic cells","volume":"52","author":"Roelofs","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imbio.2015.12.007_bib0180","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1136\/ard.2007.086421","article-title":"Type I interferons might form the link between Toll-like receptor (TLR) 3\/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA)","volume":"68","author":"Roelofs","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.imbio.2015.12.007_bib0185","article-title":"Emerging role of endosomal toll-like receptors in rheumatoid arthritis","volume":"5","author":"Thwaites","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0190","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI26078","article-title":"Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis","volume":"116","author":"Prinz","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2015.12.007_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.08.010","article-title":"Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management","volume":"239","author":"Gambuzza","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0200","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/cmi.2012.61","article-title":"TLR signaling in B-cell development and activation","volume":"10","author":"Hua","year":"2013","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0205","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.4049\/jimmunol.1401720","article-title":"B cell-intrinsic TLR7 signaling is essential for the development of spontaneous germinal centers","volume":"193","author":"Soni","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0210","doi-asserted-by":"crossref","first-page":"15319","DOI":"10.1074\/jbc.R700009200","article-title":"Toll-like receptors and type I interferons","volume":"282","author":"Uematsu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imbio.2015.12.007_bib0215","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0220","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.cr.7290309","article-title":"The host type I interferon response to viral and bacterial infections","volume":"15","author":"Perry","year":"2005","journal-title":"Cell. Res."},{"key":"10.1016\/j.imbio.2015.12.007_bib0225","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.4049\/jimmunol.174.4.1932","article-title":"IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29","volume":"174","author":"Sir\u00e9n","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0230","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.4049\/jimmunol.178.10.6208","article-title":"Sensitization to TLR7 agonist in IFN-beta-preactivated dendritic cells","volume":"178","author":"Severa","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0235","doi-asserted-by":"crossref","first-page":"e70626","DOI":"10.1371\/journal.pone.0070626","article-title":"Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-\u03b2 includes upregulation of TLR7 in plasmacytoid dendritic cells","volume":"8","author":"Derkow","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.imbio.2015.12.007_bib0240","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaut.2009.11.001","article-title":"Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice","volume":"34","author":"Santiago-Raber","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imbio.2015.12.007_bib0245","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jneuroim.2010.01.006","article-title":"The TLR7 agonist, imiquimod, increases IFN-beta production and reduces the severity of experimental autoimmune encephalomyelitis","volume":"221","author":"O'Brien","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2015.12.007_bib0250","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrd3203","article-title":"Targeting Toll-like receptors: emerging therapeutics?","volume":"9","author":"Hennessy","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.imbio.2015.12.007_bib0255","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1038\/ncomms7119","article-title":"Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseases","volume":"6","author":"Kanno","year":"2015","journal-title":"Nat. Commun."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S017129851530108X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S017129851530108X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:40:16Z","timestamp":1759250416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S017129851530108X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S017129851530108X"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2015.12.007","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein\u2013Barr virus infection","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2015.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}